Press Releases
Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Rezolute Receives Priority Medicines (PRIME) Eligibility from European Medicines Agency for Enhanced Regulatory Support of RZ358 in Congenital Hyperinsulinism
Wednesday, October 18, 2023Rezolute Inc a clinicalstage biopharmaceutical company committed to developing novel transformative therapies for serious metabolic and rare diseases today announced that the European Medicines Agency
SELLAS Announces Positive Initial Topline Phase 2a Data of SLS009 in Acute Myeloid Leukemia
Tuesday, October 17, 2023SELLAS Life Sciences Group Inc a latestage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications today announced positive initial topline data
Fortress Biotech Subsidiary Helocyte Announces Option Agreement with City of Hope for Exclusive Worldwide Rights to use a Novel Bispecific CMV/HIV CAR T Cell Therapy (optionally in combination with Triplex) for the Treatment of Adults Living with HIV-1
Tuesday, October 17, 2023Helocyte Inc a subsidiary company of Fortress Biotech Inc Today announced that it executed an exclusive option agreement with City of Hope for patent rights to use Triplex a cytomegalovirus vaccine in combination
ContraFect Announces FDA Clearance of CF-370 IND Application to Proceed With Phase 1 Clinical Study
Tuesday, October 17, 2023ContraFect Corporation a clinicalstage biotechnology company focused on the discovery and development of direct lytic agents DLAs including lysins and amurin peptides today announces that the US Food and Drug Administration FDA
Legochem Biosciences Enters Worldwide Licensing Agreement With Glycotope for Antibody Drug Conjugate Development
Monday, October 16, 2023LegoChem Biosciences Inc LCB and Glycotope GmbH Glycotope have entered into an exclusive worldwide licensing agreement to develop an antibody drug conjugate ADC by combining LCBs proprietary ADC technology
Santhera Receives Positive CHMP Opinion Recommending Approval of AGAMREE® (Vamorolone) for the Treatment of Duchenne Muscular Dystrophy
Saturday, October 14, 2023Santhera Pharmaceuticals announces that the CHMP adopted a positive opinion in favor of approval of AGAMREE vamorolone for the treatment of DMD patients aged years and older In its recommendation for approval
Harmony Biosciences Announces Topline Data From Phase 3 Intune Study Evaluating Pitolisant in Patients With Idiopathic Hypersomnia
Saturday, October 14, 2023Harmony Biosciences Holdings Inc a pharmaceutical company dedicated to developing and commercializing innovative therapies for patients with rare neurological diseases
The New Picus® 2 Sets a New Standard for Connected Electronic Pipettes
Friday, October 13, 2023The Life Science Group Sartorius introduces the Picus Electronic Pipette the latest addition to its portfolio of electronic pipettes With a combination of advanced connectivity and excellent performance Picus sets a new standard
RespireRx Pharmaceuticals Inc.’s Subsidiary ResolutionRx Ltd Enters into Master Services Agreement for Dronabinol Manufacturing and Related Services
Friday, October 13, 2023RespireRx Pharmaceuticals Inc OTC Pink Market RSPI RespireRx or the Company focused on the discovery and development of innovative and revolutionary
T2 Biosystems Announces FDA 510(k) Submission to Expand the Pathogen Detection on its FDA-Cleared T2Bacteria Panel to Include Detection of Acinetobacter baumannii
Friday, October 13, 2023T Biosystems Inc NASDAQTTOO a leader in the rapid detection of sepsiscausing pathogens and antibiotic resistance genes today announced that it has submitted
